Completed PHASE1 INTERVENTIONAL 2-arm NCT01935206

Effect of High Dose Naloxone on Secondary Hyperalgesia

Effect of a High-dose Naloxone Infusion on Secondary Hyperalgesia After a First-degree Burn

Sponsor: Rigshospitalet, Denmark

Conditions Hyperalgesia Naloxone Opioid Antagonist Pain

Interventions Naloxone (2 mg/kg) Placebo

Updated 5 times since 2017 Last updated: Feb 24, 2014 Started: Jun 30, 2013 Primary completion: Nov 30, 2013 Completion: Nov 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01935206, this PHASE1 trial focuses on Hyperalgesia and Naloxone and remains completed. Sponsored by Rigshospitalet, Denmark, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Jun 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rigshospitalet, Denmark

Data source: Rigshospitalet, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Denmark